Murfreesboro Medical Clinic, P.A.
Murfreesboro Medical Clinic, P.A. was paid $19.79M by Medicaid between Jan 2018 and Dec 2024, across 133 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoMURFREESBORO MEDICAL CLINIC, P.A.
MURFREESBORO, TN 37129
MURFREESBORO, TN 37129
33aNPI1487604609assigned 05/10/2006
33bProvider typeSpecialist
28Total paid$19.79M
24GClaims715,112
24DCodes billed133
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#3 of 252
Median peer was paid$57K
This provider vs. median347×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 69,745 | $1.92M | |
| 2019 | 85,208 | $2.37M | |
| 2020 | 80,337 | $2.30M | |
| 2021 | 96,995 | $2.93M | |
| 2022 | 117,875 | $3.48M | |
| 2023 | 113,640 | $3.52M | |
| 2024incomplete | 151,312 | $3.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 144,880 | 130,117 | $5.28M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 16% | 61,092 | 54,073 | $3.09M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 57,114 | 52,515 | $2.54M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.8% | 27,632 | 25,801 | $1.94M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.7% | 28,045 | 24,481 | $1.73M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.2% | 12,402 | 11,542 | $841K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.4% | 20,257 | 18,757 | $678K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.5% | 11,896 | 11,110 | $502K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 29,622 | 13,453 | $340K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 4,342 | 3,937 | $332K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.6% | 4,282 | 3,724 | $313K |
| 92587 | <1% | 8,803 | 7,879 | $189K |
121 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,879 | $188K |
| 87430 | <1% | 16,704 | $148K | |
| 96161 | <1% | 11,252 | $130K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,174 | $126K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,477 | $115K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,570 | $107K |
| 96160 | <1% | 9,410 | $104K | |
| 99174 | <1% | 9,681 | $79K | |
| 95117 | <1% | 7,160 | $79K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,255 | $69K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,438 | $59K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 385 | $58K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 4,149 | $48K |
| 92567 | <1% | 3,647 | $43K | |
| 90670 | <1% | 13,874 | $42K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,107 | $39K |
| 30140 | <1% | 160 | $39K | |
| 99177 | <1% | 7,263 | $38K | |
| 74018 | <1% | 2,015 | $35K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,330 | $33K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 194 | $32K |
| 99383 | <1% | 399 | $28K | |
| 92552 | <1% | 1,934 | $28K | |
| 87807 | <1% | 3,167 | $26K | |
| 92551 | <1% | 2,872 | $24K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,055 | $24K |
| 96127 | <1% | 5,632 | $23K | |
| 90671 | <1% | 5,541 | $22K | |
| 81001 | <1% | 7,246 | $17K | |
| 00160 | <1% | 124 | $15K | |
| 90651 | <1% | 1,292 | $13K | |
| 90723 | <1% | 11,341 | $12K | |
| 90680 | <1% | 9,702 | $10K | |
| 85018 | <1% | 4,329 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,550 | $8K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 55 | $8K |
| 84481 | <1% | 1,250 | $7K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 16 | $6K |
| 90686 | <1% | 7,256 | $6K | |
| 90734 | <1% | 709 | $6K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,241 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 403 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 229 | $5K |
| 85014 | <1% | 2,551 | $5K | |
| 90648 | <1% | 19,252 | $4K | |
| 99381 | <1% | 69 | $4K | |
| 84439 | <1% | 1,515 | $4K | |
| 90674 | <1% | 2,989 | $4K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 170 | $4K |
| 99384 | <1% | 44 | $4K | |
| 90688 | <1% | 5,156 | $4K | |
| 90633 | <1% | 5,019 | $4K | |
| 76536 | <1% | 104 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 233 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 78 | $3K |
| 90710 | <1% | 494 | $3K | |
| 73630 | <1% | 178 | $3K | |
| 86140 | <1% | 1,941 | $3K | |
| 95251 | <1% | 213 | $3K | |
| 92557 | <1% | 115 | $3K | |
| 99460 | <1% | 52 | $3K | |
| 99382 | <1% | 40 | $2K | |
| 80061 | Lipid panel | <1% | 275 | $2K |
| 96380 | <1% | 107 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 990 | $2K |
| 31575 | <1% | 26 | $2K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 40 | $2K |
| 85652 | <1% | 1,974 | $2K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 13 | $2K |
| 99417 | Prolong home eval add 15m | <1% | 53 | $1K |
| 90661 | <1% | 1,434 | $1K | |
| 90716 | <1% | 482 | $1K | |
| 70486 | <1% | 13 | $1K | |
| 80305 | <1% | 2,125 | $1K | |
| 31231 | <1% | 13 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 96 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 81 | $1K |
| 00126 | <1% | 13 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 243 | $979.03 |
| 95886 | <1% | 13 | $954.34 | |
| 11721 | <1% | 150 | $875.11 | |
| 76641 | <1% | 12 | $847.00 | |
| 93000 | <1% | 87 | $710.17 | |
| 73130 | <1% | 59 | $703.96 | |
| 90707 | <1% | 394 | $680.70 | |
| 92588 | <1% | 13 | $653.78 | |
| 95115 | <1% | 78 | $642.90 | |
| 90696 | <1% | 364 | $632.64 | |
| 96103 | <1% | 96 | $539.65 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 29 | $531.58 |
| 73610 | <1% | 32 | $465.21 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 39 | $390.43 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 17 | $371.56 |
| 85730 | <1% | 101 | $336.41 | |
| 90715 | <1% | 226 | $329.52 | |
| 90620 | <1% | 26 | $275.06 | |
| 81025 | <1% | 45 | $174.20 | |
| 90700 | <1% | 361 | $160.93 | |
| 3074F | <1% | 11,289 | $130.00 | |
| 3078F | <1% | 10,719 | $110.00 | |
| 94760 | <1% | 201 | $90.40 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 29 | $79.74 |
| 99173 | <1% | 12 | $61.07 | |
| 82570 | <1% | 16 | $44.88 | |
| 3079F | <1% | 97 | $40.00 | |
| 85610 | <1% | 18 | $31.85 | |
| 1159F | <1% | 21,927 | $10.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 14 | $9.76 |
| 82043 | <1% | 15 | $8.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 26 | $4.27 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 75 | $3.56 |
| 90656 | <1% | 87 | $0.12 | |
| 90381 | <1% | 23 | $0.01 | |
| 3008F | 0% | 7,393 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 5,328 | $0.00 |
| 99024 | 0% | 555 | $0.00 | |
| 1036F | 0% | 282 | $0.00 | |
| 3048F | 0% | 14 | $0.00 | |
| 3075F | 0% | 25 | $0.00 | |
| 4274F | 0% | 3,448 | $0.00 | |
| 99072 | 0% | 352 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPEAY, JOSEPH (CEO)